200 related articles for article (PubMed ID: 17725409)
21. Screening and prevention of breast cancer in primary care.
Tice JA; Kerlikowske K
Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
[TBL] [Abstract][Full Text] [Related]
22. The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS).
Leach MO; Eeles RA; Turnbull LW; Dixon AK; Brown J; Hoff RJ; Coulthard A; Dixon JM; Easton DF; Evans DG; Gilbert FJ; Hawnaur J; Hayes C; Kessar P; Lakhani S; Liney G; Moss SM; Padhani AP; Pointon LJ; Sydenham M; Walker LG; Warren RM; Haites NE; Morrison P; Cole T; Rayter Z; Donaldson A; Shere M; Rankin J; Goudie D; Steel CM; Davidson R; Chu C; Ellis I; Mackay J; Hodgson SV; Homfray T; Douglas F; Quarrell OW; Eccles DM; Gilbert FG; Crothers G; Walker CP; Jones A; Slack N; Britton P; Sheppard DG; Walsh J; Whitehouse G; Teh W; Rankin S; Boggis C; Potterton J; McLean L; Gordon PA; Rubin C;
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):107-14. PubMed ID: 12585664
[TBL] [Abstract][Full Text] [Related]
23. The molecular pathology of hereditary breast cancer.
Palacios J; Robles-Frías MJ; Castilla MA; López-García MA; Benítez J
Pathobiology; 2008; 75(2):85-94. PubMed ID: 18544963
[TBL] [Abstract][Full Text] [Related]
24. [Breast cancer screening different from that used for the general population: who is concerned and with which approach?].
Chappuis PO
Rev Med Suisse; 2006 May; 2(66):1296-8, 1301-2, 1304-5. PubMed ID: 16775990
[TBL] [Abstract][Full Text] [Related]
25. The case against BRCA 1 and 2 testing.
Lin C; Sasaki T; Strumwasser A; Harken A
Surgery; 2011 Jun; 149(6):731-4. PubMed ID: 21621683
[No Abstract] [Full Text] [Related]
26. Breast cancer: new technologies for risk assessment and diagnosis.
Wright T; McGechan A
Mol Diagn; 2003; 7(1):49-55. PubMed ID: 14529321
[TBL] [Abstract][Full Text] [Related]
27. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.
Fatouros M; Baltoyiannis G; Roukos DH
Ann Surg Oncol; 2008 Jan; 15(1):21-33. PubMed ID: 17940826
[TBL] [Abstract][Full Text] [Related]
28. Precision medicine meets public health: population screening for BRCA1 and BRCA2.
Levy-Lahad E; Lahad A; King MC
J Natl Cancer Inst; 2015 Jan; 107(1):420. PubMed ID: 25550384
[No Abstract] [Full Text] [Related]
29. MR imaging in screening women at increased risk for breast cancer.
Boetes C; Stoutjesdijk M
Magn Reson Imaging Clin N Am; 2001 May; 9(2):357-72, vii. PubMed ID: 11493425
[TBL] [Abstract][Full Text] [Related]
30. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain.
Esteban Cardeñosa E; Bolufer Gilabert P; Palanca Suela S; Oltra Soler S; Barragán González E; Velasco Sampedro E; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E;
Breast Cancer Res Treat; 2008 Nov; 112(1):69-73. PubMed ID: 18060494
[TBL] [Abstract][Full Text] [Related]
31. BRCA testing: ethics lessons for the new genetics.
Sherwin S
Clin Invest Med; 2004 Feb; 27(1):19-22. PubMed ID: 15061582
[No Abstract] [Full Text] [Related]
32. [Family and genetic risk of breast cancer].
De Pauw A; Stoppa-Lyonnet D
Soins; 2013 Jun; (776):30-2. PubMed ID: 23878882
[TBL] [Abstract][Full Text] [Related]
33. Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer.
Liljegren A; von Wachenfeldt A; Azavedo E; Eloranta S; Grundström H; Ståhlbom AK; Sundbom A; Sundén P; Svane G; Ulitzsch D; Arver B
Breast Cancer Res Treat; 2018 Apr; 168(3):655-666. PubMed ID: 29318406
[TBL] [Abstract][Full Text] [Related]
34. Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families.
Katki HA; Gail MH; Greene MH
Lancet Oncol; 2007 Dec; 8(12):1042-1043. PubMed ID: 18054868
[No Abstract] [Full Text] [Related]
35. Screening and follow-up of the patient at high risk for breast cancer.
Willey SC; Cocilovo C
Obstet Gynecol; 2007 Dec; 110(6):1404-16. PubMed ID: 18055740
[TBL] [Abstract][Full Text] [Related]
36. Can genetic testing guide treatment in breast cancer?
Tutt A; Ashworth A
Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
[TBL] [Abstract][Full Text] [Related]
37. [Molecular genetics and clinics of hereditary breast cancer].
Schmutzler RK
Verh Dtsch Ges Pathol; 2005; 89():25-34. PubMed ID: 18035669
[TBL] [Abstract][Full Text] [Related]
38. [Hereditary/familial breast cancer].
Fukutomi T
Nihon Rinsho; 2007 Jun; 65 Suppl 6():245-8. PubMed ID: 17682162
[No Abstract] [Full Text] [Related]
39. Should women at high risk of breast cancer have screening magnetic resonance imaging (MRI)?
Houssami N; Wilson R
Breast; 2007 Feb; 16(1):2-4. PubMed ID: 17189696
[No Abstract] [Full Text] [Related]
40. Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.
Evans DG; Young K; Bulman M; Shenton A; Wallace A; Lalloo F
Clin Genet; 2008 Apr; 73(4):338-45. PubMed ID: 18312450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
